In addition, two studies that performed meta-analyses on previous randomized controlled clinical trials for efficacy of CKI in lung cancer (24) or esophageal cancer patients (25) receiving radiotherapy also suggest that CKI reduces radiation pneumonitis and esophagitis in those patients. This evidence concerns the gene CHKA and lung cancer.